Kangpu Biopharmaceuticals, Ltd.

Biopharma, Clinical Trials, Health Care, Pharmaceutical
Founded in 2011-01-01
Shanghai, Shanghai, China
http://www.kangpugroup.com/
For Profit

About Kangpu Biopharmaceuticals, Ltd.

Kangpu is focused on developing small molecule drugs targeting immuno-modulating sites to develop treatments for cancer, autoimmune diseases and inflammation. The company has developed proprietary technologies to generate and degrade ubiquitin-protein. It also has a drug discovery combination platform called X-Synergy®.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 52963569 USD
  • Last Funding: 250000000 CNY (Series B)
  • Funding Status: Early Stage Venture

Technology Stack

Kangpu Biopharmaceuticals, Ltd. actively uses None products in their tech stack.

Market Presence

Industries: Biopharma, Clinical Trials, Health Care, Pharmaceutical

Headquarters: Shanghai, Shanghai, China